In this week’s biotech bi-weekly, we explore recent product launches, partnerships and publications that have sparked interest in the biotech space, from a new brain organoid assay to presenting the latest lab automation innovations. Products Unveiling a new brain organoid assay 28bio (LA, USA) has announced the launch of the CNS-3D Induced Alzheimer’s Model, a brain organoid assay enabling researchers to evaluate whether therapeutic candidates can reduce or prevent disease progression in patients. The CNS-3D Induced Alzheimer’s Model includes human neuroimmune organoids and exogeneous amyloid beta oligomers to evaluate Alzheimer’s-relevant phenotypes. This assay-ready solution enables researchers to reproduce complex neuroimmune…
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
The latest news and journal updates delivered straight to your inbox when you want it
Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
Priority registration to webinars, panel discussions and events
Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!